📊 PHR Key Takeaways
Is Phreesia, Inc. (PHR) a Good Investment?
Phreesia exhibits weak fundamental characteristics including anemic 2.7% revenue growth, dangerously thin profit margins (2.3% net, 5.2% operating), and poor returns on capital (0.8% ROE, 0.4% ROA). While the balance sheet is solid and free cash flow is positive, the business fails to generate attractive returns relative to its $666M asset base, indicating capital allocation challenges in a competitive healthcare IT market.
Phreesia, Inc. Key Strengths (PHR)
- Fortress balance sheet with minimal debt ($612K long-term) and $76.4M cash position
- Positive free cash flow generation ($19.6M, 15% FCF margin) demonstrates underlying cash generation despite thin net profitability
- Strong liquidity position (1.76x current ratio) provides financial flexibility and operational stability
PHR Stock Risks: Phreesia, Inc. Investment Risks
- Stagnant revenue growth of 2.7% YoY is unacceptable for a technology-enabled healthcare platform and signals market saturation or competitive displacement
- Severely compressed profit margins (2.3% net, 5.2% operating) indicate structural competitive pressure, pricing power loss, or uncontrolled cost structure in commoditized market
- Abysmal return metrics (0.8% ROE, 0.4% ROA) demonstrate the business cannot efficiently deploy capital, with $666M in assets generating only $3M net income annually
Key Metrics to Watch
- YoY revenue growth acceleration above 10% - critical to prove market relevance and growth runway
- Operating margin expansion to minimum 12-15% - essential to demonstrate sustainable profitability and operational leverage
- Return on equity improvement above 5-8% - necessary to validate efficient capital deployment and shareholder value creation
Phreesia, Inc. (PHR) Financial Metrics & Key Ratios
💡 AI Analyst Insight
Phreesia, Inc. presents a mixed fundamental picture. Review the detailed metrics above to form your own investment thesis.
PHR Profit Margin, ROE & Profitability Analysis
PHR vs Services Sector: How Phreesia, Inc. Compares
How Phreesia, Inc. compares to Services sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is Phreesia, Inc. Stock Overvalued? PHR Valuation Analysis 2026
Based on fundamental analysis, Phreesia, Inc. has mixed fundamental signals relative to the Services sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
Phreesia, Inc. Balance Sheet: PHR Debt, Cash & Liquidity
PHR Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: Phreesia, Inc.'s revenue has remained relatively flat over the 5-year period, with a 0% decline. The most recent EPS of $-2.51 indicates the company is currently unprofitable.
PHR Revenue Growth, EPS Growth & YoY Performance
PHR Quarterly Earnings & Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2027 | $115.9M | $3.0M | $0.05 |
| Q3 2026 | $106.8M | $654.0K | $0.02 |
| Q2 2026 | $102.1M | $654.0K | $0.01 |
| Q1 2026 | $101.2M | -$3.9M | $-0.07 |
| Q3 2025 | $91.6M | -$14.4M | $-0.25 |
| Q2 2025 | $85.8M | -$18.0M | $-0.31 |
| Q1 2025 | $83.8M | -$19.7M | $-0.35 |
| Q3 2024 | $73.1M | -$31.9M | $-0.58 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
Phreesia, Inc. Dividends, Buybacks & Capital Allocation
PHR SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for Phreesia, Inc. (CIK: 0001412408)
📋 Recent SEC Filings
❓ Frequently Asked Questions about PHR
What is the AI rating for PHR?
Phreesia, Inc. (PHR) has an AI grade of C with 60% confidence, based on fundamental analysis of SEC EDGAR filings.
What are PHR's key strengths?
Claude: Fortress balance sheet with minimal debt ($612K long-term) and $76.4M cash position. Positive free cash flow generation ($19.6M, 15% FCF margin) demonstrates underlying cash generation despite thin net profitability.
What are the risks of investing in PHR?
Claude: Stagnant revenue growth of 2.7% YoY is unacceptable for a technology-enabled healthcare platform and signals market saturation or competitive displacement. Severely compressed profit margins (2.3% net, 5.2% operating) indicate structural competitive pressure, pricing power loss, or uncontrolled cost structure in commoditized market.
What is PHR's revenue and growth?
Phreesia, Inc. reported revenue of $130.9M.
Does PHR pay dividends?
Phreesia, Inc. does not currently pay dividends.
Where can I find PHR SEC filings?
Official SEC filings for Phreesia, Inc. (CIK: 0001412408) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is PHR's EPS?
Phreesia, Inc. has a diluted EPS of $0.05.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined grade reflects both perspectives for balanced insights.
What is PHR's fundamental grade?
Based on our AI fundamental analysis in May 2026, Phreesia, Inc. has a C grade with 60% confidence. Review the strengths and risks sections above for full context. This is not investment advice.
Is PHR stock overvalued or undervalued?
Valuation metrics for PHR: ROE of 0.8% (sector avg: 16%), net margin of 2.3% (sector avg: 10%). Compare these metrics with sector averages to assess valuation.
What is PHR's AI grade for 2026?
Our dual AI analysis gives Phreesia, Inc. a combined C grade for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is PHR's free cash flow?
Phreesia, Inc.'s operating cash flow is $23.9M, with capital expenditures of $4.3M. FCF margin is 15.0%.
How does PHR compare to other Services stocks?
Vs Services sector averages: Net margin 2.3% (avg: 10%), ROE 0.8% (avg: 16%), current ratio 1.76 (avg: 1.5).